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ABSTRACT 
 
This thesis focuses on evaluation, improvement and development of mass 
spectrometry based proteomic strategies for identification and quantitation of 
proteins. Development of such strategies is important to achieve a better 
understanding of regulatory mechanisms of individual cell types, both during 
normal development and during the onset and progression of diseases. Cells 
derived from the central nervous system served as model systems. Proteins 
secreted by these cells can be predicted to be involved in a variety of biological 
processes, including protective/survival effects, promotion of brain plasticity or 
intercellular communication. Secreted proteins might also be potential 
biomarkers of clinical importance, a tool for early detection and diagnosis of 
diseases. A challenge in the analysis of conditioned media is that the secreted 
proteins are much less abundant than the media proteins. A strategy involving 
preparative two-dimensional gel electrophoresis based on liquid phase 
separation identified several secreted proteins in well-defined conditioned 
medium from neural stem/progenitor cells. Their identification demonstrates the 
potential of this approach in identifying lower abundance proteins in the 
medium. In a serum-containing astrocyte conditioned medium, secreted proteins 
were identified using metabolic labeling. The proteins released were 
distinguished from the components of the medium in the mass spectrometric 
analysis by the labeled amino acid that was incorporated into the cellular 
proteins during culturing. Both strategies employed on the conditioned media 
can be used as initial screening tools to identify released proteins. Furthermore, 
they can be extended to most cells lines for studying secreted proteins. Mass 
spectrometric methods based on metabolic labeling have also shown great 
promise for identification and quantitation of proteins in complex mixtures. A 
prefractionation step involving micro-scale iso-electric focusing in liquid phase 
of whole cell extracts was found to be useful in the analysis. The number of 
identified proteins was drastically increased and the quantitation of lower 
abundance proteins was improved as compared with direct analysis of the same 
sample.  
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